Your Location：
Home >
Browse articles >
Regulation of Alzheimer's Disease by Chinese Medicine Based on BDNF/TrkB Signaling Pathway： A Review
Updated：2024-09-12
Previous|Next

    • Regulation of Alzheimer's Disease by Chinese Medicine Based on BDNF/TrkB Signaling Pathway： A Review

      Enhanced Publication
    • YUE Liuping , SUN Yongkang , XU Fangbiao , SONG Yanbo , WANG Xinzhi
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 20, Pages: 274-282(2024)

    • DOI： 10.13422/j.cnki.syfjx.20240719     

      CLC：

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • References

  • Publication Info

  • Metrics

388

Views

806

Downloads

2

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Danggui Shaoyaosan Alleviates Cognitive Impairment by Regulating Ketone Body Metabolism and Glutamate/AMPAR Pathway
Mechanisms of Shangxia Liangji Danin Improving Cognitive Function in AD Mice Based on PI3K/Akt Signaling Pathway
Mechanisms of Action of Angelica sinensis in Prevention and Treatment of Alzheimer's Disease： A Review
Si Junzitang Ameliorates Alzheimer's Disease by Regulating Keap1/Nrf2/HO-1 Signaling Pathway
Herbal Textual Research on Bambusae Succus in Famous Classical Formulas

Related Author

SUN Shibiao
PAN Xiaolong
WEI Zhihui
LIU Feixiang
ZHANG Yunke
WANG Shasha
WANG Xin
GONG Kexin

Related Institution

Henan University of Chinese Medicine
The First Affiliated Hospital of Henan University of Chinese Medicine
Science and Technology Innovation Center， Guangzhou University of Chinese Medicine
Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine
Hubei University of Chinese Medicine